You're reading the free version. Trader adds the live tape and alerts.
Start tracking
MLYS Sale Disclosure
Rodman David Malcom · SEC Form 4 · Filed Jul 15, 2026
Sale
Calculated transaction value
$168.95K
Rodman David Malcom Chief Medical Officer
MLYS
Transaction date
Jul 15, 2026
Public filing date
Jul 15, 2026
Filing lag
Filed same day
MLYS daily price context
Close on/before transaction
$27.31
Jul 15, 2026
First close after public filing
$27.08
Jul 16, 2026
30-day return after filing
-5.32%
Through Aug 14, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 6,349 shares @ $26.61
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001933414-26-000099
Filing cohort
Transactions in this filing
Showing 8 of 8
Trades
8
Issuers
1
Estimated value
$659.04K
Buys / sales
0 / 2
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Mineralys Therapeutics, Inc. MLYS Current | Sale | Jul 15, 2026 | $168.95K |
| Mineralys Therapeutics, Inc. MLYS | Exercise | Jul 13, 2026 | $59.38K |
| Mineralys Therapeutics, Inc. MLYS | Exercise | Jul 13, 2026 | $6.86K |
| Mineralys Therapeutics, Inc. MLYS | Sale | Jul 13, 2026 | $387.72K |
| Mineralys Therapeutics, Inc. MLYS | Exercise | Jul 13, 2026 | $0 |
| Mineralys Therapeutics, Inc. MLYS | Exercise | Jul 13, 2026 | $0 |
| Mineralys Therapeutics, Inc. MLYS | Exercise | Jul 13, 2026 | $36.13K |
| Mineralys Therapeutics, Inc. MLYS | Exercise | Jul 13, 2026 | $0 |